×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
für erwachsene CML-Patienten - uniklinikum-jena.deund+... · Imatinib/Dasatinib/Nilotinib mit Asciminib Ziele • MMR, MR4, MR4 .5 unter TKI plus ABL (6, 12, 18, 24 Monate) • Toleranz
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form